6-Fluoro-3-cyclopropylbromobenzene

Catalog No.: 
ACEEGP132
CAS No.: 
1353854-28-0
Molecular Formula: 
C9H8BrF
Molecular Weight: 
215.07
6-Fluoro-3-cyclopropylbromobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$176.00InquiryInquiry
1g95%$411.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluoro-3-cyclopropylbromobenzene
IUPAC Name2-bromo-4-cyclopropyl-1-fluorobenzene
MDL No.MFCD21099995
Molecular FormulaC9H8BrF
Molecular Weight215.07
SMILESFC1=C(Br)C=C(C2CC2)C=C1
InChI KeyPOXKPISEORGJLY-UHFFFAOYSA-N
Synonym2-bromo-4-cyclopropyl-1-fluorobenzene;Benzene, 2-bromo-4-cyclopropyl-1-fluoro-;3-Bromo-4-fluoro-1-cyclopropylbenzene
CAS No.1353854-28-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACEEGP132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACEEGP132 route product structure diagram
    ACEEGP1321353854-28-0
Inquiry

2. ACEEGP132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMESG597 route compound structure diagram
    ACMESG597811842-30-5In Stock
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACEEGP132 route product structure diagram
    ACEEGP1321353854-28-0
Inquiry

3. ACEEGP132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEEGP132 route product structure diagram
    ACEEGP1321353854-28-0
Inquiry

Comments (0)